Analysts Set Transcat, Inc. (NASDAQ:TRNS) Price Target at $111.50

Shares of Transcat, Inc. (NASDAQ:TRNSGet Free Report) have been given an average recommendation of “Hold” by the five ratings firms that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $111.50.

A number of research firms have recently commented on TRNS. Northland Securities reaffirmed a “market perform” rating and issued a $85.00 price target (down from $110.00) on shares of Transcat in a report on Wednesday, January 29th. StockNews.com lowered Transcat from a “hold” rating to a “sell” rating in a report on Wednesday, February 5th. Oppenheimer cut Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Finally, HC Wainwright cut their price objective on shares of Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th.

Read Our Latest Report on TRNS

Insider Activity

In related news, Director Craig D. Cairns acquired 1,200 shares of the company’s stock in a transaction dated Friday, January 31st. The stock was bought at an average cost of $77.02 per share, with a total value of $92,424.00. Following the acquisition, the director now owns 1,910 shares of the company’s stock, valued at approximately $147,108.20. The trade was a 169.01 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 2.30% of the company’s stock.

Institutional Investors Weigh In On Transcat

Hedge funds have recently added to or reduced their stakes in the company. Jones Financial Companies Lllp raised its holdings in shares of Transcat by 686.7% during the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company’s stock valued at $37,000 after buying an additional 309 shares in the last quarter. Aquatic Capital Management LLC grew its position in Transcat by 1,052.0% during the fourth quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company’s stock valued at $122,000 after acquiring an additional 1,052 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of Transcat by 10,137.5% during the first quarter. GAMMA Investing LLC now owns 1,638 shares of the scientific and technical instruments company’s stock worth $122,000 after acquiring an additional 1,622 shares in the last quarter. Morgan Dempsey Capital Management LLC bought a new stake in shares of Transcat in the 4th quarter worth approximately $143,000. Finally, SG Americas Securities LLC purchased a new stake in shares of Transcat in the 4th quarter valued at $182,000. Institutional investors own 98.34% of the company’s stock.

Transcat Trading Up 3.6 %

Shares of Transcat stock opened at $86.28 on Friday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42. The stock has a market capitalization of $803.18 million, a P/E ratio of 46.64 and a beta of 0.67. Transcat has a 52-week low of $67.56 and a 52-week high of $147.12. The stock’s 50-day simple moving average is $76.70 and its 200 day simple moving average is $96.31.

Transcat (NASDAQ:TRNSGet Free Report) last announced its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same quarter in the previous year, the company posted $0.56 EPS. As a group, research analysts anticipate that Transcat will post 2.3 EPS for the current year.

Transcat Company Profile

(Get Free Report

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Read More

Analyst Recommendations for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.